Moderna Inc (0QF)

Frankfurt
Currency in EUR
21.0450
+0.1450(+0.69%)
Delayed Data·
0QF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
0QF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.805021.4700
52 wk Range
20.1750155.5000
Key Statistics
Edit
Bid/Ask
21.115 / 21.59
Prev. Close
20.9
Open
20.805
Day's Range
20.805-21.47
52 wk Range
20.175-155.5
Volume
522
Average Vol. (3m)
1.01K
1-Year Change
-82.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0QF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Moderna Inc Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Employees
5800
Market
Germany

Compare 0QF to Peers and Sector

Metrics to compare
0QF
Peers
Sector
Relationship
P/E Ratio
−2.7x4.5x−0.5x
PEG Ratio
−0.060.020.00
Price / Book
0.9x1.1x2.6x
Price / LTM Sales
2.9x2.8x2.9x
Upside (Analyst Target)
-144.1%45.8%
Fair Value Upside
Unlock12.4%8.6%Unlock

Earnings

Latest Release
Feb 21, 2025
EPS / Forecast
-2.92 / --
Revenue / Forecast
966.00M / --
EPS Revisions
Last 90 days

People Also Watch

507.33
BRKb
+0.78%
232.64
AVGO
+0.22%
152.61
QCOM
-0.24%
134.83
NVDA
-0.38%
95.45
MU
+0.14%

FAQ

What Is the Moderna Inc (0QF) Stock Price Today?

The Moderna Inc stock price today is 21.05

What Stock Exchange Does Moderna Inc Trade On?

Moderna Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Moderna Inc?

The stock symbol for Moderna Inc is "0QF."

What Is the Moderna Inc Market Cap?

As of today, Moderna Inc market cap is 8.16B.

What Is Moderna Inc's Earnings Per Share (TTM)?

The Moderna Inc EPS (TTM) is -8.72.

From a Technical Analysis Perspective, Is 0QF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.